SBD

By SBDScience

SBD episodes

May 14, 2018 P014 - Declínio renal progressivo no DM1 - Tatiana Valente
Progressive renal decline: the new paradigm of diabetic nephropathy in type 1 diabetes. Diabetes Care. 2015 Jun;38(6):954-62
6 min
May 14, 2018 P014 - Declínio renal progressivo no DM1 - Tatiana Valente
Progressive renal decline: the new paradigm of diabetic nephropathy in type 1 diabetes. Diabetes Care. 2015 Jun;38(6):954-62
6 min
May 14, 2018 P013 - Microbioma intestinal e obesidade infantil - Márcio Krakauer
The gut microbiome and childhood obesity: connecting the dots. Child Obes. 2015 Jun;11(3):227-30
7 min
May 14, 2018 P013 - Microbioma intestinal e obesidade infantil - Márcio Krakauer
The gut microbiome and childhood obesity: connecting the dots. Child Obes. 2015 Jun;11(3):227-30
7 min
May 14, 2018 P012 - Comprometimento cognitivo está associado à neuropatia periférica em DM2? - Sérgio Vêncio
Is cognitive impairment associated with the presence and severity of peripheral neuropathy in patients with type 2 diabetes mellitus? Diabetol Metab Syndr. 2015 Jun 7;7:51
4 min
May 14, 2018 P012 - Comprometimento cognitivo está associado à neuropatia periférica em DM2? - Sérgio Vêncio
Is cognitive impairment associated with the presence and severity of peripheral neuropathy in patients with type 2 diabetes mellitus? Diabetol Metab Syndr. 2015 Jun 7;7:51
4 min
May 14, 2018 P011 - Mecanismo de secreção de glucagon pela Dapagliflozina - João Eduardo Nunes Salles
Therapy: SGLT2 inhibitor dapagliflozin promotes glucagon secretion in α islet cells. Nat Rev Endocrinol. 2015 Jul;11(7):382
6 min
May 14, 2018 P011 - Mecanismo de secreção de glucagon pela Dapagliflozina - João Eduardo Nunes Salles
Therapy: SGLT2 inhibitor dapagliflozin promotes glucagon secretion in α islet cells. Nat Rev Endocrinol. 2015 Jul;11(7):382
6 min
May 14, 2018 P010 - Dapagliflozina no DM1 - Mônica Gabbay
Exploring the potential of the SGLT2 inhibitor dapagliflozin in type 1 diabetes: a randomized, double-blind, placebo-controlled pilot study. Diabetes Care. 2015 Mar;38(3):412-9
6 min
May 14, 2018 P010 - Dapagliflozina no DM1 - Mônica Gabbay
Exploring the potential of the SGLT2 inhibitor dapagliflozin in type 1 diabetes: a randomized, double-blind, placebo-controlled pilot study. Diabetes Care. 2015 Mar;38(3):412-9
6 min

About SBD

From the publisher's feed

Acompanhe as últimas novidades sobre o diabetes, tratamentos e muito mais, com os Podcasts da Sociedade Brasileira de Diabetes, exclusivos para profissionais da saúde.

Share SBD

Sign up to save your podcasts

SBD

SBD episodes

About SBD

More shows like SBD

Comentaristas

Entrementes

15 Minutos em Emergência - Manole Educação

O Assunto

Afya Cardiopapers

Ta de Clinicagem

Jota Jota Podcast | Joel Jota

WW – William Waack

Desestresse

Nefropapers

EndoDirect - Endocrinologia e Metabologia

Afya Endocrinopapers